Kate Cross is a Consultant Neonatal and Paediatric Surgeon at Great Ormond Street Hospital and the Speciality Lead for Specialist Neonatal and Paediatric Surgery at Great Ormond Street Hospital (GOSH).
Kate is also the lead oncology surgeon in the department with a special interest in neuroblastoma surgery.
In addition to her expertise in oncology surgery, Kate also has a keen interest in advanced laparoscopic and thoracoscopic surgery including advanced neonatal operations. She performs laparoscopic diaphragmatic hernia repair, malrotation and volvulus correction, inguinal hernia repair, orchidopexy, appendicectomy, pyloromyotomy, fundoplication, gastrostomy, cholecystectomy and splenectomy as well as other advanced procedures including thoracoscopic oesophageal atresia repair and thoracoscopic aortopexy in children from birth (including preterm infants).
She attends the antenatal counseling clinics on a monthly basis at UCLH.
Qualifications and training
Kate graduated from the University of Newcastle, NSW Australia, Bachelor of Medicine with Honours in 1997. She became a Fellow of the Australasian College of Surgeons (FRACS) in Paediatric Surgery in 2007 after training at the Sydney Children’s Hospital and the Children’s Hospital Westmead (Australia) and Great Ormond Street Hospital (UK).
Her first consultant post was at the Children’s Hospital Westmead in Sydney in 2007 before moving to back to London and Great Ormond Street Hospital where she has worked as a consultant since 2009.
She was awarded the Child and Family Award at GOSH in 2012.
Kate is strongly supportive of clinical research and is actively involved in many departmental and multicentre trials. Book chapters and publications include vascular malformations, neonatal surgery, neuroblastoma and minimally invasive surgery as well as oesophageal atresia and other congenital anomalies, inguinal hernia, orchidopexy, neuroblastoma surgery and a new treatment modality for volvulus and intestinal ischaemia.
She is a member of the British Association of Paediatric Surgeons (BAPS) and the Australian and New Zealand Association of Paediatric Surgeons (ANZAPS) as well as the International Society of Paediatric Surgical Oncology (IPSO) and the International Society of Paediatric Oncology Europe Neuroblastoma (SIOPEN). She has been an invited speaker at a number of national and international meetings.